Table 1

Characteristics of patients with SLE used to derive the risk formula for the broader definition of cardiovascular events

Patient CharacteristicNumber (%)
Sex
 Female1587 (92%)
 Male134 (8%)
Race
 White898 (52%)
 Black688 (40%)
 Other135 (8%)
Age group (years)
 20–29519 (30%)
 30–39528 (31%)
 40–49356 (21%)
 50–59222 (13%)
 60+96 (6%)
Years since SLE diagnosis at cohort entry
 <2682 (40%)
 2–4289 (17%)
 4–7242 (14%)
 7–10167 (10%)
 10+339 (20%)
Duration of follow-up (years)
 2–5749 (44%)
 5–10425 (25%)
 10–15271 (16%)
 15+276 (16%)
Mean Systolic Blood Pressure (mmHg)*
 <120802 (47%)
 120–129461 (27%)
 130–139261 (15%)
 140+197 (11%)
Treated for hypertension596 (35%)
Current or Past Smoking599 (35%)
Mean Total Serum Cholesterol (mg/dl)*
 <140181 (11%)
 140-199945 (56%)
 200+576 (34%)
Diabetes151 (9%)
Mean SLEDAI*
 0186 (11%)
 >0–2757 (44%)
 3+778 (45%)
History of Lupus Anticoagulant345 (20%)
Low mean C3*403 (23%)
Mean eGFR*
 ≥901173 (69%)
 60–89385 (23%)
 <60130 (8%)

  • *Mean during the first year on the cohort.

  • eGFR, estimated glomerular filtration rate; SLEDAI, SLE Disease Activity Index.